Markus Jerling
Technik-/Wissenschafts-/F&E-Leiter bei ONCOZENGE AB
Aktive Positionen von Markus Jerling
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONCOZENGE AB | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2021 | - |
KANCERA AB | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 | - |
DIAMYD MEDICAL AB | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Corporate Officer/Principal | - | - |
Karriereverlauf von Markus Jerling
Ehemalige bekannte Positionen von Markus Jerling
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.01.2004 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01.01.1998 | 01.01.2000 |
Astra Arcus AB | Corporate Officer/Principal | 01.01.1995 | 01.01.1998 |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2007 | - |
Ausbildung von Markus Jerling
Karolinska Institutet | Doctorate Degree |
Statistik
International
Schweden | 7 |
Vereinigte Staaten | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ONCOZENGE AB | Health Technology |
KANCERA AB | Health Technology |
DIAMYD MEDICAL AB | Health Technology |
Private Unternehmen | 4 |
---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Astra Arcus AB |
- Börse
- Insiders
- Markus Jerling
- Erfahrung